The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Rabinstein et al., N Engl J Med 355(4):418-421 July 27, 2006.

Correction
PreviousPrevious
Volume 355:1076 September 7, 2006 Number 10

Clopidogrel for the Prevention of Atherothrombotic Events

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Rabinstein, A. A.
Clopidogrel for the Prevention of Atherothrombotic Events . On page 420, the second line of the reply letter by Topol should have read, "there was a benefit of dual antiplatelet therapy with respect to the reduction in the rate of nonfatal stroke (1.9 percent in the group given aspirin and clopidogrel vs. 2.4 percent in the group given aspirin and placebo, P=0.03)," not "(2.4 percent in the group given aspirin and clopidogrel vs. 1.9 percent in the group given aspirin and placebo, P=0.03)," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.